Testing effectiveness (Phase 2)Looking for participantsNCT04186520
What this trial is testing
CAR-20/19-T Cells in Patients With Relapsed Refractory B Cell Malignancies
Who this might be right for
Non Hodgkin Lymphoma (NHL)Mantle Cell Lymphoma (MCL)Chronic Lymphocytic Leukemia (CLL)+5 more
Medical College of Wisconsin 100